143 related articles for article (PubMed ID: 26040563)
1. Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma.
Gavine PR; Wang M; Yu D; Hu E; Huang C; Xia J; Su X; Fan J; Zhang T; Ye Q; Zheng L; Zhu G; Qian Z; Luo Q; Hou YY; Ji Q
BMC Cancer; 2015 Jun; 15():454. PubMed ID: 26040563
[TBL] [Abstract][Full Text] [Related]
2. Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation.
Lochhead PA; Clark J; Wang LZ; Gilmour L; Squires M; Gilley R; Foxton C; Newell DR; Wedge SR; Cook SJ
Cell Cycle; 2016; 15(4):506-18. PubMed ID: 26959608
[TBL] [Abstract][Full Text] [Related]
3. ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry.
Zen K; Yasui K; Nakajima T; Zen Y; Zen K; Gen Y; Mitsuyoshi H; Minami M; Mitsufuji S; Tanaka S; Itoh Y; Nakanuma Y; Taniwaki M; Arii S; Okanoue T; Yoshikawa T
Genes Chromosomes Cancer; 2009 Feb; 48(2):109-20. PubMed ID: 18973138
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase 7 promotes cell proliferation, migration and invasion in SOSP-M human osteosarcoma cell line.
Huang Y; Yao J; Zhu B; Zhang J; Sun T
Tumori; 2017 Sep; 103(5):483-488. PubMed ID: 26350187
[TBL] [Abstract][Full Text] [Related]
5. A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLC.
Dompe N; Klijn C; Watson SA; Leng K; Port J; Cuellar T; Watanabe C; Haley B; Neve R; Evangelista M; Stokoe D
PLoS One; 2018; 13(6):e0199264. PubMed ID: 29912950
[TBL] [Abstract][Full Text] [Related]
6. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.
Sturla LM; Cowan CW; Guenther L; Castellino RC; Kim JY; Pomeroy SL
Cancer Res; 2005 Jul; 65(13):5683-9. PubMed ID: 15994942
[TBL] [Abstract][Full Text] [Related]
7. MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma.
Tesser-Gamba F; Lopes LJ; Petrilli AS; Toledo SR
Mol Carcinog; 2016 Nov; 55(11):1700-1713. PubMed ID: 26460937
[TBL] [Abstract][Full Text] [Related]
8. The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells.
Tusa I; Gagliardi S; Tubita A; Pandolfi S; Menconi A; Lulli M; Dello Sbarba P; Stecca B; Rovida E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681917
[TBL] [Abstract][Full Text] [Related]
9. ERK5 regulates basic fibroblast growth factor-induced type 1 plasminogen activator inhibitor expression and cell proliferation in lung fibroblasts.
Han JH; Hwang AR; Nam DH; Kim S; Choi HC; Lim JH; Woo CH
Life Sci; 2015 Aug; 135():1-8. PubMed ID: 26032256
[TBL] [Abstract][Full Text] [Related]
10. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones.
Deng X; Elkins JM; Zhang J; Yang Q; Erazo T; Gomez N; Choi HG; Wang J; Dzamko N; Lee JD; Sim T; Kim N; Alessi DR; Lizcano JM; Knapp S; Gray NS
Eur J Med Chem; 2013; 70():758-67. PubMed ID: 24239623
[TBL] [Abstract][Full Text] [Related]
12. Trop2 inhibition suppresses the proliferation and invasion of laryngeal carcinoma cells via the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway.
Wang XD; Wang Q; Chen XL; Huang JF; Yin Y; Da P; Wu H
Mol Med Rep; 2015 Jul; 12(1):865-70. PubMed ID: 25779928
[TBL] [Abstract][Full Text] [Related]
13. Impact of ERK5 on the Hallmarks of Cancer.
Stecca B; Rovida E
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901834
[TBL] [Abstract][Full Text] [Related]
14. Role of MAPK7 in cell proliferation and metastasis in ovarian cancer.
Dai J; Wang T; Wang W; Zhang S; Liao Y; Chen J
Int J Clin Exp Pathol; 2015; 8(9):10444-51. PubMed ID: 26617753
[TBL] [Abstract][Full Text] [Related]
15. ERK5: structure, regulation and function.
Nithianandarajah-Jones GN; Wilm B; Goldring CE; Müller J; Cross MJ
Cell Signal; 2012 Nov; 24(11):2187-96. PubMed ID: 22800864
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Aurora-A enhances invasion and matrix metalloproteinase-2 expression in esophageal squamous cell carcinoma cells.
Wang X; Lu N; Niu B; Chen X; Xie J; Cheng N
Mol Cancer Res; 2012 May; 10(5):588-96. PubMed ID: 22522455
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma.
Su CM; Su YH; Chiu CF; Chang YW; Hong CC; Yu YH; Ho YS; Wu CH; Yen CS; Su JL
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S767-75. PubMed ID: 25212831
[TBL] [Abstract][Full Text] [Related]
18. Phosphoprotein analysis reveals MEK inhibition as a way to target non-small cell lung cancer tumor initiating cells.
Lundholm L; Hååg P; Juntti T; Lewensohn R; Viktorsson K
Int J Radiat Biol; 2014 Aug; 90(8):718-26. PubMed ID: 24646078
[TBL] [Abstract][Full Text] [Related]
19. Identification of pharmacological inhibitors of the MEK5/ERK5 pathway.
Tatake RJ; O'Neill MM; Kennedy CA; Wayne AL; Jakes S; Wu D; Kugler SZ; Kashem MA; Kaplita P; Snow RJ
Biochem Biophys Res Commun; 2008 Dec; 377(1):120-5. PubMed ID: 18834865
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
